<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20500892</PMID><DateCompleted><Year>2010</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2010</Year><Month>May</Month><Day>26</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Monoclonal antibody induced with inactived EV71-Hn2 virus protects mice against lethal EV71-Hn2 virus infection.</ArticleTitle><Pagination><StartPage>106</StartPage><MedlinePgn>106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1743-422X-7-106</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Enterovirus 71 (EV71) is a viral pathogen that belongs to the Picornaviridae family, EV71-infected children can develop severe neurological complications leading to rapid clinical deterioration and death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In this study, several monoclonal antibodies (MAbs) were produced by immunizing mice with the inactived EV71 Henan (Hn2) virus strain. The isolated MAbs were characterised by in vitro neutralizing analysis and peptide ELISA. ELISA assay showed that the neutralizing monoclonal antibody 4E8 specifically reacted with synthetic peptides which contain amino acid 240-250 and 250-260 of EV71 VP1. The in vivo protection assay showed that 4E8 can protect two-day-old BALB/c mice against the lethal challenge of EV71 virus.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The MAb 4E8 could be a promising candidate to be humanized and used for treatment of EV71 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Guo-hui</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Fengtai District, Beijing, PR China. changguohui999@yahoo.com.cn</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yan-jun</ForeName><Initials>YJ</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiao-yan</ForeName><Initials>XY</Initials></Author><Author ValidYN="Y"><LastName>Si</LastName><ForeName>Bing-yin</ForeName><Initials>BY</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Qing-yu</ForeName><Initials>QY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>05</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007116" MajorTopicYN="Y">Immunization, Passive</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>9</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2010</Year><Month>5</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20500892</ArticleId><ArticleId IdType="pmc">PMC2887433</ArticleId><ArticleId IdType="doi">10.1186/1743-422X-7-106</ArticleId><ArticleId IdType="pii">1743-422X-7-106</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt NJ, Lennette EH, Ho HH. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 1974;129:304&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara A, Yoneyama T, Takami S, Hashimoto I. Genetic and phenotypic characteristics of enterovirus 71 isolates from patients with encephalitis and with hand, foot and mouth disease associated with enterovirus 71 infection. Arch Virol. 1984;79:273&#x2013;283. doi: 10.1007/BF01310816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01310816</ArticleId><ArticleId IdType="pubmed">6320781</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, Sakamoto M, Hongo S, Murayama S, Hayasaka K. Frequent importation of Enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbio. 2005;43:6171&#x2013;6175. doi: 10.1128/JCM.43.12.6171-6175.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.12.6171-6175.2005</ArticleId><ArticleId IdType="pmc">PMC1317214</ArticleId><ArticleId IdType="pubmed">16333123</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 1979;60:329&#x2013;340. doi: 10.1007/BF01317504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317504</ArticleId><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Abubakar S, Chee HY, Shafee N, Chua KB, Lam SK. Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997. Scand J Infect Dis. 1999;31:331&#x2013;335. doi: 10.1080/00365549950163734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365549950163734</ArticleId><ArticleId IdType="pubmed">10528868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF. An epidemic of enterovirus 71 infection in Taiwan. New Engl J Med. 1999;341:929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Li RQ, Chen LJ, Wang YM, Zhang HR, He X. Genetic characteristics of enterovirus 71 isolated in Beijing, 2006-2008. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30:45&#x2013;49. Chinese.</Citation><ArticleIdList><ArticleId IdType="pubmed">19565848</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, He YQ, Hong Y, Zhu JP. Genetic Characteristics of Human Enterovirus 71 and Coxsackievirus A16 Circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbio. 2005;43:3835&#x2013;3839. doi: 10.1128/JCM.43.8.3835-3839.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.43.8.3835-3839.2005</ArticleId><ArticleId IdType="pmc">PMC1233905</ArticleId><ArticleId IdType="pubmed">16081920</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang GH, Lin L, Luo YJ, Cai LJ, Wu XY, Xu HM, Zhu QY. Sequence analysis of six enterovirus 71 strains with different virulences in humans. Virus Res. 2010;151:66&#x2013;73. doi: 10.1016/j.virusres.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2010.04.001</ArticleId><ArticleId IdType="pubmed">20398708</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Silva EE, Winkler MT, Pallansch MA. Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis. 1996;2:231&#x2013;233. doi: 10.3201/eid0203.960312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0203.960312</ArticleId><ArticleId IdType="pmc">PMC2626804</ArticleId><ArticleId IdType="pubmed">8903236</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195&#x2013;205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DGW, Alonso S, Phoon MC, Ramachandran NP, Chow VTK, Poh CL. Identification of neutralizing linear epitopes from the VP1 capsid protein of enterovirus 71 using synthetic peptides. Virus Res. 2007;125:61&#x2013;68. doi: 10.1016/j.virusres.2006.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2006.12.005</ArticleId><ArticleId IdType="pubmed">17222936</ArticleId></ArticleIdList></Reference><Reference><Citation>Guang DM, Foo W, Alonso S, Chow VTK, Poh CL. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect. 2007;9:1299&#x2013;1306. doi: 10.1016/j.micinf.2007.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2007.06.002</ArticleId><ArticleId IdType="pubmed">17890123</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu CH, Chu C, He CC, Lin TY. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect. 2006;8:1&#x2013;8. doi: 10.1016/j.micinf.2006.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2006.01.021</ArticleId><ArticleId IdType="pubmed">16815726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. Protection against enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine. 2001;20:895&#x2013;904. doi: 10.1016/S0264-410X(01)00385-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(01)00385-1</ArticleId><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolaskar AS, Tongaonkar PC. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990;276:172&#x2013;174. doi: 10.1016/0014-5793(90)80535-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(90)80535-Q</ArticleId><ArticleId IdType="pubmed">1702393</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of Enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, Von Ziepe GI. New enterovirus type associated with epidemic of aseptic menigitis and: or hand, foot, and mouth disease. Lancet. 1974;2:112&#x2013;119. doi: 10.1016/S0140-6736(74)91684-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(74)91684-5</ArticleId><ArticleId IdType="pubmed">4136956</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341:936&#x2013;942. doi: 10.1056/NEJM199909233411302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura-Kuroda J, Yasui K. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J Immunol. 1988;141:3606&#x2013;3610.</Citation><ArticleIdList><ArticleId IdType="pubmed">2460542</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang YC, Lin TY, Lin YJ, Lien RI, Chou YH. Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. Eur J Pediatr. 2001;160:91&#x2013;94. doi: 10.1007/s004310000640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004310000640</ArticleId><ArticleId IdType="pubmed">11271397</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller TJ, Condie D. A case of protracted coxsackie virus meningoencephalitis in a marginally immunodeficient child treated successfully with intravenous immunoglobulin. J Neurol Sci. 1995;129:131&#x2013;133. doi: 10.1016/0022-510X(94)00261-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)00261-L</ArticleId><ArticleId IdType="pubmed">7608726</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas AAM, Brioen P, Boye A. A monoclonal antibody that neutralizes poliovirus by cross-linking virions. J of Virol. 1985;54:7&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC254753</ArticleId><ArticleId IdType="pubmed">2983121</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith TJ, Olson NH, Cheng RH, Chase ES, Baker TS. Structure of a human rhinovirus-bivalently bound antibody complex: implications for viral neutralization and antibody flexibility. Proceedings of the National Academy of Sciences. USA. 1993;90:7015&#x2013;7018. doi: 10.1073/pnas.90.15.7015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.15.7015</ArticleId><ArticleId IdType="pmc">PMC47066</ArticleId><ArticleId IdType="pubmed">8394005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lal SK, Kumar P, Yeo WM, Kar-Roy A, Chow VT. The VP1 protein of human Enterovirus 71 self-associates via an interaction domain spanning amino acids 66-297. J Med Virol. 2006;78:582&#x2013;590. doi: 10.1002/jmv.20579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20579</ArticleId><ArticleId IdType="pubmed">16555287</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CS, Cardosa MJ. High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1. Arch Virol. 2007;152:1069&#x2013;1073. doi: 10.1007/s00705-007-0941-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-007-0941-1</ArticleId><ArticleId IdType="pubmed">17318736</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. A simple method of estimating 50 percent end-points. Am J Hyg. 1938;27:493&#x2013;497.</Citation></Reference><Reference><Citation>Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495&#x2013;497. doi: 10.1038/256495a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/256495a0</ArticleId><ArticleId IdType="pubmed">1172191</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>